Search

everythinglearnresearchcommunity

for

Search:↓

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.